以腹内压和氧合指数指导液体复苏对重症急性胰腺炎患者的临床疗效
该回顾性研究纳入2018年1月至2021年8月山东第一医科大学附属青州医院急诊重症监护病房84例重症急性胰腺炎患者,按入院时液体平衡状态分为正平衡组43例和负平衡组41例。治疗72小时后,负平衡组复苏目标达标率82.93%(34/41)显著高于正平衡组62.79%(27/43),入院1周新发机械通气率21.95%(9/41)显著低于正平衡组41.86%(18/43),两组总住院时间无显著差异。负平衡组腹内压较治疗前显著下降,两组氧合指数均较治疗前显著升高。作者认为以腹内压和氧合指数指导液体治疗可实现有效液体复苏并改善预后。
要点
- 治疗72小时后负平衡组复苏达标率82.93%(34/41)显著高于正平衡组62.79%(27/43)(P<0.05)。
- 入院1周负平衡组新发机械通气率21.95%(9/41)显著低于正平衡组41.86%(18/43)(P<0.05)。
- 负平衡组治疗72小时后腹内压较治疗前显著下降(11.4±1.8 mmHg vs. 15.2±1.9 mmHg,P<0.05),正平衡组无显著差异(11.9±2.0 mmHg vs. 11.7±2.1 mmHg,P>0.05)。
- 两组治疗72小时后氧合指数均较治疗前显著升高:正平衡组299.8±51.4 mmHg vs. 220.5±50.4 mmHg,负平衡组309.9±50.9 mmHg vs. 215.4±49.7 mmHg(均P<0.05)。
- 两组总住院时间无显著差异(负平衡组41.2±10.9天 vs. 正平衡组39.1±11.5天,P>0.05);治疗后70例存活、14例死亡(正平衡组9例、负平衡组5例)。
适用人群与场景
- 2018年1月至2021年8月山东第一医科大学附属青州医院急诊重症监护病房收治的84例重症急性胰腺炎患者。
- 按入院时液体平衡状态分为正平衡组43例和负平衡组41例。
处置流程与药物剂量
- 采用腹内压(IAP)和氧合指数(PaO2/FiO2)作为液体复苏终点指导液体治疗。
- 治疗72小时后记录累计液体平衡:正平衡组(5 219.5±1 038.4)mL,负平衡组(-3 542.4±1 310.6)mL。
研究设计与关键结果
- 研究类型为回顾性研究,纳入84例重症急性胰腺炎患者,正平衡组43例、负平衡组41例。
- 治疗72小时后正平衡组腹内压11.9±2.0 mmHg vs. 治疗前11.7±2.1 mmHg,无显著差异(P>0.05);氧合指数299.8±51.4 mmHg vs. 220.5±50.4 mmHg,显著升高(P<0.05)。
- 治疗72小时后负平衡组腹内压11.4±1.8 mmHg vs. 治疗前15.2±1.9 mmHg,显著下降(P<0.05);氧合指数309.9±50.9 mmHg vs. 215.4±49.7 mmHg,显著升高(P<0.05)。
- 治疗72小时后复苏目标达标率负平衡组82.93%(34/41)显著高于正平衡组62.79%(27/43)(P<0.05)。
- 入院1周新发机械通气率负平衡组21.95%(9/41)显著低于正平衡组41.86%(18/43)(P<0.05)。
- 总住院时间负平衡组41.2±10.9天 vs. 正平衡组39.1±11.5天,无显著差异(P>0.05)。
- 治疗后70例存活、14例死亡,其中正平衡组死亡9例、负平衡组死亡5例。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,以腹内压和氧合指数指导液体治疗可在重症急性胰腺炎患者中实现有效液体复苏,该治疗策略有效改善了患者预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the effect of the liquid resuscitation therapy strategy using intra-abdominal pressure (IAP) and oxygenation index (PaO2/FiO2) as the end point in patients with severe acute pancreatitis (SAP).
METHODS: A retrospective study was performed, including 84 patients with SAP in emergency intensive care unit of Qingzhou Hospital Affiliated to Shandong First Medical University from January 2018 to August 2021. According to the status of fluid balance at admission, all patients were divided into the positive fluid balance group (43 cases) and the negative fluid balance group (41 cases). The clinical data including gender, age, etiology, underlying disease, acute physiology and chronic health evaluation II (APACHE II) and sequential organ failure assessment (SOFA) of all patients were collected. Fluid balance, PaO2/FiO2, IAP, compliance rate, new mechanical ventilation rate and overall hospital stay of 1 week after admission were recorded and compared between the two groups.
RESULTS: After 72 hours of treatment, the cumulative fluid balance was (5 219.5±1 038.4) mL in the positive fluid balance group; IAP was higher than that before treatment [mmHg (1 mmHg ≈ 0.133 kPa): 11.9±2.0 vs. 11.7±2.1], but no significant difference was found (P > 0.05); PaO2/FiO2 was significantly higher than that before treatment (mmHg: 299.8±51.4 vs. 220.5±50.4, P < 0.05). After 72 hours of treatment, the cumulative fluid balance in negative fluid balance group was (-3 542.4±1 310.6) mL; IAP was significantly lower than before treatment (mmHg: 11.4±1.8 vs. 15.2±1.9, P < 0.05); PaO2/FiO2 was significantly higher than that before treatment (mmHg: 309.9±50.9 vs. 215.4±49.7, P < 0.05). In the fluid resuscitation goals, after 72 hours of treatment, the compliance rate in the negative fluid balance group was significantly higher than that in the positive fluid balance group [82.93% (34/41) vs. 62.79% (27/43), P < 0.05]; 1 week after admission, the new mechanical ventilation rate in the negative fluid balance group was significantly lower than that in the positive fluid balance group [21.95% (9/41) vs. 41.86% (18/43), P < 0.05]; however, there was no significant difference in overall hospital stay between the two groups (days: 41.2±10.9 vs. 39.1±11.5, P > 0.05). After treatment, 70 patients survived and 14 patients died (including 9 cases in the positive fluid balance group and 5 cases in the negative fluid balance group).
CONCLUSIONS: Using IAP and PaO2/FiO2 to guide liquid therapy could result in effective fluid resuscitation in SAP. The treatment strategy effectively improved prognosis of patients with SAP.
参考来源
- Zhang H, Zhao J, Zhang Y, et al. [Clinical effect of fluid resuscitation guided by intra-abdominal pressure and oxygenation index for severe acute pancreatitis patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35728856. doi:10.3760/cma.j.cn121430-20211115-01720
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。